Cc1cccc(C(=O)Oc2ccccc2C2C[C@]3(C)CC(=O)NC3N2C(=O)c2cccc(C)c2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?